openPR Logo
Press release

Recent Study says, Anti-Inflammatory Therapeutics Market in Asia-Pacific value set to grow $24.5 Billion by 2020

04-15-2019 03:37 PM CET | Health & Medicine

Press release from: Allied Market Research

Asia-Pacific Anti-Inflammatory Therapeutics Market

Asia-Pacific Anti-Inflammatory Therapeutics Market

The Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% during the period of 2015-2020.

The arthritis segment would continue to lead the Asia Pacific anti-inflammatory therapeutics market through 2020. China anti-inflammatory therapeutics market is forecast to grow at the highest CAGR of 13.9% during the forecast period.

Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/1175?utm_source=opr_sank

Inflammation is a nonspecific immune defense mechanism of the body triggered due to injuries, bacterial or viral infections or any damage to the internal or external organs. When this inflammation persists for longer duration it can lead to chronic diseases such as atherosclerosis and rheumatoid arthritis, to name few. Currently, reduction of inflammation particularly in chronic diseases is the widely accepted therapeutic approach adopted by physicians.

Rising incidences of autoimmune and respiratory diseases, increasing R&D investments in China and India and large amount of biosimilar drugs in the development pipeline would drive the growth of the Asia-Pacific anti-inflammatory therapeutics market. Furthermore, factors such as existence of established markets for NSAIDs and corticosteroids, large adoption of OTC (over the counter) NSAIDs, such as ibuprofen and naproxen, in China and India and government initiatives in the Asia-Pacific region would further boost the market growth. However, the adverse effects associated with prolonged consumption of drugs such as NSAIDs and corticosteroids and issues of uncertain patent legislations, such as compulsory licensing in India, would limit the market growth. High price sensitivity in countries such as India and China would be the key challenge for drug innovators to launch their patented drugs in the market.

The anti-inflammatory biologics segment dominated the market in 2014 and is expected to display the highest growth rate over the forecast period. This is due to the unmatched benefits offered by biological drugs and rapid adoption in countries like Japan along with improving healthcare access and increasing healthcare expenditures. Popularity of corticosteroids has been decreasing due to the issues of withdrawal symptoms and toxicity.

Japan is the leading market for patented as well as biologic drugs. However, government in Japan is now focusing on establishment of effective generic drugs. On the other hand, China is projected to emerge as the new market leader in the Asia-Pacific anti-inflammatory therapeutics market by 2020 due to rapidly developing economy, growing healthcare expenditure and huge patient base. In India, the launch of biosimilars and constantly improving per capita healthcare spending would be the key factors facilitating the growth of anti-inflammatory therapeutics market.

Key Findings of the Anti-inflammatory Therapeutics Asia-Pacific Market:

• China is expected to take over Japan by 2018 in the Asia Pacific anti-inflammatory therapeutics market
• India anti-inflammatory therapeutics market is projected to account for around 13% share in the Asia-Pacific market by 2020
• China and India would govern around half of the Asia-Pacific NSAID market by 2020
• Japan accounted for around 1/3rd share in the anti-inflammatory biologics market in 2014, highest among all
• Arthritis indication was the major revenue-generating segment in the APAC anti-inflammatory indication market in 2014
• Psoriasis indication is projected to grow at a CAGR of 10.7%, fastest among all indications

Companies have been adopting strategies such as collaborations, indication expansions and product launches as their key strategies to overcome the patent expiry issues of existing drugs and to gain additional market share. The key companies profiled in this report are Pfizer, Inc., AbbVie, Inc., Johnson & Johnson, GlaxoSmithKline plc, Merck & CO., Inc. Novartis AG, F. Hoffman La Roche AG, Eli Lily and Company, AstraZeneca PLC and Amgen, Inc.

Flat 20% Discount on All License Type.. https://www.alliedmarketresearch.com/checkout/869484
*Offer Valid Till 20th April 2019

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client's insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Recent Study says, Anti-Inflammatory Therapeutics Market in Asia-Pacific value set to grow $24.5 Billion by 2020 here

News-ID: 1703622 • Views:

More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529 What Are Urinary Drainage Bags? Urinary drainage bags are specialized medical devices designed to collect
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031. The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Billion by 2030; Growing at a CAGR of 17.2%
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario. Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of 5.6%
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in

All 5 Releases


More Releases for Asia

Asia Private Equity Firm, Asia Private Equity Management, Asia Private Equity Se …
The private equity market in China has been rapidly growing in recent years. Private equity (PE) refers to the purchase of shares in a company that are not publicly traded on a stock exchange. PE firms typically target companies that are undervalued or in need of capital for growth, and aim to improve the company's operations and financial performance before selling it at a higher value. https://boomingfaucet.com/ Asia Private Equity Consulting E-mail:nolan@pandacuads.com In China,
South East Asia Business Jet Market And Top Key Players are Asia Corporate Jet, …
By 2022, the South East Asia Business Jet Markets estimated to reach US$ XX Mn, up from US$ XX Mn in 2016, growing at a CAGR of XX% during the forecast period. The Global Business Jet Market, currently at 21 million USD, contributes the highest share in the market and is poised to grow at the fastest rate in the future. The three broad categories of business jets are Small,
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022. 23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property
PEOPLEWAVE WINS ASIA TECH PODCAST PITCHDECK ASIA 2019 AWARDS
15 January 2019, Singapore – Peoplewave, Asia’s leading data-driven HR technology company, won the Asia Tech Podcast (ATP) Pitchdeck Asia 2019 Awards, being awarded “Startup Most Likely to Succeed in 2019". The 2019 Pitchdeck Asia Awards is an opportunity for the Asian Startup Ecosystem to shine a spotlight on some of its best startups. The awards were decided by a public vote. More than 7,200 votes were cast by registered LinkedIn
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia Equipping Asia’s navies with the latest diving technology for asymmetric warfare and operations SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting
Asia Diligence – Specialist Investigative Due Diligence for Asia & Beyond
Asia Diligence today announced the opening of its European Customer Services office in the United Kingdom. The office is to be managed by Steve Fowler and will focus on providing services to Asia Diligence’s European customers. Asia Diligence is also planning to open a US office in the near future, which will provide customer service to its US and North American clients. Asked to comment on the move, Luke Palmer, the